Why Most Forex Accounts Blow Up: The 5 Account Killers (Lesson 11)

We just published a new video on MCP Labs Forex. It covers Why Most Forex Accounts Blow Up: The 5 Account Killers (Lesson 11). Watch it here and read our summary below.

What this video covers

Lesson 11 opens the risk module: why most retail trading accounts lose money, and the five account killers (trading too big, no stop loss, revenge trading, doubling up with martingale or grids, and trading without a plan), each with the maths that shows how it destroys an account, plus what surviving traders do differently.

Lesson 11 of the free course "Forex From Zero to Automated" by MCP Labs Forex.

Next lesson: Lesson 12: The 1% rule and lot size

QUIZ: You risk 2% of your current balance on every trade and lose five trades in a row. Roughly how much of your account have you lost? Is that survivable? Answer in the comments.

CHAPTERS

0:00 The warning most traders scroll past

0:59 Killer 1: trading too big

1:37 Killer 2: no stop loss

2:15 Killer 3: revenge trading

2:51 Killer 4: doubling up (martingale)

4:02 Killer 5: no plan, no edge

4:26 Your questions

5:50 What survivors do + recap

6:38 Quiz and homework

Sources: Retail loss disclosures: ESMA / FCA CFD rules. Streak probabilities and martingale maths: exact calculations.

Education, not financial advice. Trading forex, gold and CFDs on margin is high risk; practise on a demo account first. Narration voice is AI-generated.

A product of MCP Labs, created by Tshivhidzo (Moss) Mbedzi.

Run the EA from these videos

Everything shown here runs on Apex Drawdown Zero for MT5 — a selective MT5 Expert Advisor with a stop-loss on every trade and risk-based sizing (V9 has no account-level drawdown halt; V12 does). See more clips on our videos page or subscribe on YouTube.

---

*Any results, returns or win rates mentioned in this video are examples from specific accounts and periods and are not typical or guaranteed. Trading carries substantial risk of loss. Past performance is not indicative of future results — read our full risk disclosure.*